Building A Bridge To A COVID-19 Vaccine: Hydroxychloroquine And BCG Lead Prevention Pipeline

More than 40 Phase III trials are assessing pre- and post-exposure prophylaxis of SARS-CoV-2 infection.

Coronavirus globe

More from Clinical Trials

More from R&D